42 related articles for article (PubMed ID: 17389313)
1. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease.
Zgaljardic DJ; Borod JC; Foldi NS; Mattis PJ; Gordon MF; Feigin A; Eidelberg D
J Clin Exp Neuropsychol; 2006 Oct; 28(7):1127-44. PubMed ID: 16840240
[TBL] [Abstract][Full Text] [Related]
2. Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.
Irmady K; Hale CR; Qadri R; Fak J; Simelane S; Carroll T; Przedborski S; Darnell RB
Nat Commun; 2023 Jul; 14(1):3956. PubMed ID: 37407548
[TBL] [Abstract][Full Text] [Related]
3. Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.
Disbrow EA; Glassy ND; Dressler EM; Russo K; Franz EA; Turner RS; Ventura MI; Hinkley L; Zweig R; Nagarajan SS; Ledbetter CR; Sigvardt KA
PLoS One; 2022; 17(3):e0257711. PubMed ID: 35245294
[TBL] [Abstract][Full Text] [Related]
4. Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease.
Cholerton BA; Poston KL; Yang L; Rosenthal LS; Dawson TM; Pantelyat A; Edwards KL; Tian L; Quinn JF; Chung KA; Hiller AL; Hu SC; Montine TJ; Zabetian CP
J Clin Exp Neuropsychol; 2021 Jul; 43(5):469-480. PubMed ID: 34355669
[No Abstract] [Full Text] [Related]
5. Gender Differences and Quality of Life in Parkinson's Disease.
Crispino P; Gino M; Barbagelata E; Ciarambino T; Politi C; Ambrosino I; Ragusa R; Marranzano M; Biondi A; Vacante M
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33383855
[TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases.
Solés-Tarrés I; Cabezas-Llobet N; Vaudry D; Xifró X
Front Cell Neurosci; 2020; 14():221. PubMed ID: 32765225
[TBL] [Abstract][Full Text] [Related]
7. The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease.
Bayram E; Kaplan N; Shan G; Caldwell JZK
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Jul; 27(4):581-594. PubMed ID: 31411534
[TBL] [Abstract][Full Text] [Related]
8. A Common Function of Basal Ganglia-Cortical Circuits Subserving Speed in Both Motor and Cognitive Domains.
Hanakawa T; Goldfine AM; Hallett M
eNeuro; 2017; 4(6):. PubMed ID: 29379873
[TBL] [Abstract][Full Text] [Related]
9. Long reaction times are associated with delayed brain activity in lewy body dementia.
Firbank MJ; O'Brien JT; Taylor JP
Hum Brain Mapp; 2018 Feb; 39(2):633-643. PubMed ID: 29094778
[TBL] [Abstract][Full Text] [Related]
10. Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson's Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task.
Herzallah MM; Khdour HY; Taha AB; Elmashala AM; Mousa HN; Taha MB; Ghanim Z; Sehwail MM; Misk AJ; Balsdon T; Moustafa AA; Myers CE; Gluck MA
Front Psychiatry; 2017; 8():84. PubMed ID: 28659830
[TBL] [Abstract][Full Text] [Related]
11. Modification of spectral features by nonhuman primates.
Weiss DJ; Hotchkin CF; Parks SE
Behav Brain Sci; 2014 Dec; 37(6):574-6; discussion 577-604. PubMed ID: 25514964
[TBL] [Abstract][Full Text] [Related]
12. Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms.
David FJ; Rafferty MR; Robichaud JA; Prodoehl J; Kohrt WM; Vaillancourt DE; Corcos DM
Parkinsons Dis; 2012; 2012():124527. PubMed ID: 22191068
[TBL] [Abstract][Full Text] [Related]
13. The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury.
Bales JW; Yan HQ; Ma X; Li Y; Samarasinghe R; Dixon CE
Exp Neurol; 2011 Jun; 229(2):300-7. PubMed ID: 21376040
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in Parkinson's disease: clinical characteristics and cognition.
Miller IN; Cronin-Golomb A
Mov Disord; 2010 Dec; 25(16):2695-703. PubMed ID: 20925068
[TBL] [Abstract][Full Text] [Related]
15. Pathologic correlates of dementia in individuals with Lewy body disease.
Sonnen JA; Postupna N; Larson EB; Crane PK; Rose SE; Montine KS; Leverenz JB; Montine TJ
Brain Pathol; 2010 May; 20(3):654-9. PubMed ID: 20522091
[TBL] [Abstract][Full Text] [Related]
16. Visual exploration of emotional facial expressions in Parkinson's disease.
Clark US; Neargarder S; Cronin-Golomb A
Neuropsychologia; 2010 Jun; 48(7):1901-13. PubMed ID: 20230847
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and dementia in patients with Parkinson disease.
Leverenz JB; Quinn JF; Zabetian C; Zhang J; Montine KS; Montine TJ
Curr Top Med Chem; 2009; 9(10):903-12. PubMed ID: 19754405
[TBL] [Abstract][Full Text] [Related]
18. Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum.
Sawamoto N; Honda M; Hanakawa T; Aso T; Inoue M; Toyoda H; Ishizu K; Fukuyama H; Shibasaki H
Neurology; 2007 Mar; 68(13):1062-8. PubMed ID: 17389313
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
